Indrayan kalka in renal stone

Randomized open controlled clinical study to evaluate the efficacy of Indrayan kalka in mutrashmari with special reference to Urolithiasis

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/10/046162

Enrollment

Registered

2022-10-04

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N209- Urinary calculus, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1) Predignosed patient with clinical features and USG showing calculus of size 6mm single or multiple will be taken for treatment. 2) Calculus presents in Kidney/Ureter/Bladder

Exclusion criteria

Exclusion criteria: 1) Patients with calculus more than 6mm in size. 2) Patients of shukrashmari. 3) Patients having renal failure.

Design outcomes

Primary

Measure	Time frame
Decrease in stone size in mm according to USGTimepoint: 12 Days	—

Secondary

Measure	Time frame
1) Decrease in symptoms like 2) pain burning micturition 3) dysuria 4) hematuriaTimepoint: 12 days	—

Countries

India

Contacts

Public ContactDr Achal Vijay Kanojia

Yashwant Ayurvedic Medical College PGT and RC kodoli, shalyatantra department opd no 4

drlaxminarhare@gmail.com9822189226

Outcome results